Banque Cantonale Vaudoise
- SEC CIK
- 0001793755
- Latest filing
- Jul 31, 2026
AUPH holding history
Aurinia Pharmaceuticals Inc. in every 13F filed by Banque Cantonale Vaudoise, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AUPH overviewAll 13F holders of AUPHFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −2,892−100.0% | Sold out | Holders |
| Q1 2025 | 2,892 | $23.0K | <0.1% | – | No prior filing | Holders |
| Q4 2024 | – | – | – | – | Not filed | Holders |
| Q3 2024 | 9,684 | $71.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 9,684 | $55.0K | <0.1% | +5,410+126.6% | Added | Holders |
| Q1 2024 | 4,274 | $21.0K | <0.1% | −13,229−75.6% | Reduced | Holders |
| Q4 2023 | 17,503 | $157.0K | <0.1% | −4,471−20.3% | Reduced | Holders |
| Q3 2023 | 21,974 | $171.0K | <0.1% | +5,300+31.8% | Added | Holders |
| Q2 2023 | 16,674 | $161.0K | <0.1% | −836−4.8% | Reduced | Holders |
| Q1 2023 | 17,510 | $192.0K | <0.1% | −6,556−27.2% | Reduced | Holders |
| Q4 2022 | 24,066 | $104.0K | <0.1% | −3,311−12.1% | Reduced | Holders |
| Q3 2022 | 27,377 | $205.0K | <0.1% | +3,286+13.6% | Added | Holders |
| Q2 2022 | 24,091 | $242.0K | <0.1% | +244+1.0% | Added | Holders |
| Q1 2022 | 23,847 | $296.0K | <0.1% | −7,288−23.4% | Reduced | Holders |
| Q4 2021 | 31,135 | $712.0K | <0.1% | +16,399+111.3% | Added | Holders |
| Q3 2021 | 14,736 | $326.0K | <0.1% | +8,289+128.6% | Added | Holders |
| Q2 2021 | 6,447 | $84.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 6,447 | $84.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.